Filing Details
- Accession Number:
- 0001209191-14-074299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-10 19:07:40
- Reporting Period:
- 2014-12-09
- Filing Date:
- 2014-12-10
- Accepted Time:
- 2014-12-10 19:07:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1305253 | Celladon Corp | CLDN | Biological Products, (No Disgnostic Substances) (2836) | 330971591 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1590703 | M Krisztina Zsebo | 11988 El Camino Real, Suite 650 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-09 | 41,302 | $1.12 | 42,833 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-12-09 | 41,302 | $15.00 | 1,531 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2014-12-09 | 41,302 | $0.00 | 41,302 | $1.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
555,812 | 2013-01-27 | 2022-06-14 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person.
- The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction.
- 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.